Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
CELON PHARMA Aktie jetzt für 0€ handeln | |||||
05.03. | Celon's PDE10A inhibitor reduces involuntary movements in midstage Parkinson's trial | 2 | FierceBiotech | ||
27.06.24 | Dividendenbekanntmachungen (27.06.2024) | 12.318 | wallstreetONLINE (Dividenden) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ADVENTURE INC JP3122380003 22 JPY 0,128 EUR AGC INC JP3112000009 105 JPY 0,6111 EUR ALUMINUM CORPORATION OF CHINA LTD CNE1000001T8 0... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
NOVARTIS | 103,30 | +0,37 % | Novartis Pharma AG: Novartis completes acquisition of Regulus Therapeutics | Basel, June 25, 2025 - Novartis today announced that it has successfully completed its acquisition of Regulus Therapeutics Inc. ("Regulus"). With the completion of the acquisition, shares of common... ► Artikel lesen | |
GILEAD SCIENCES | 92,00 | 0,00 % | Assembly Biosciences: ABI-4334 erreicht Studienziel - Gilead-Entscheidung steht bevor | Assembly Biosciences (WKN: A402CB) liefert weiter ab: Mit ABI-4334 fällt der erste wichtige Readout dieses Jahres positiv aus. Das HBV-Asset galt als das unsicherste im Portfolio. Die Aktie liebäugelt... ► Artikel lesen | |
AURORA CANNABIS | 3,685 | +1,38 % | Aurora Cannabis Inc (3): Aurora Cannabis expands compassionate pricing program | ||
GSK | 16,470 | +0,24 % | GSK's Benlysta Autoinjector Gets FDA Approval For Children With Active Lupus Nephritis | LONDON (dpa-AFX) - GSK plc (GSK.L) Tuesday said that the U.S. Food and Drug Administration (FDA) has approved Benlysta autoinjector for individuals aged five years and older with active lupus... ► Artikel lesen | |
TILRAY BRANDS | 0,355 | +1,89 % | Tilray Brands, Inc.: Tilray Medical erhält vom italienischen Gesundheitsministerium die erste Genehmigung für den Vertrieb von medizinischen Cannabisblüten für therapeutische Zwecke | SAVONA, Italien, June 25, 2025 (GLOBE NEWSWIRE) -- Tilray Medical ("Tilray"), ein Geschäftsbereich von Tilray Brands, Inc. (NASDAQ: TLRY und TSX: TLRY) und weltweit führender Anbieter von medizinischem... ► Artikel lesen | |
WPD PHARMACEUTICALS | 0,002 | 0,00 % | WPD Pharmaceuticals Inc (2): WPD Pharmaceuticals suspended by CSE | ||
SINOPHARM | 2,004 | -1,96 % | Dividendenbekanntmachungen (16.06.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AEGON LTD BMG0112X1056 - 0,19 EUR ALTAGAS LTD CA0213611001 0,315 CAD 0,2007 EUR ALTEN SA FR0000071946 - 1,5 EUR ALTRIA GROUP INC US02209S1033 1... ► Artikel lesen | |
BETTER PLANT SCIENCES | 0,010 | 0,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 28.05.2025 | The following instruments on Boerse Frankfurt do have their last trading day on 28.05.2025Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 28.05.2025ISIN NameBMG3728V1090 GAN... ► Artikel lesen | |
BACHEM | 62,25 | -1,19 % | Bachem Holding AG: Bachem Mourns the Loss of Company Founder Dr. H.C. Peter Grogg | Bubendorf, Switzerland--(Newsfile Corp. - June 3, 2025) - The founder and honorary chairman of Bachem (SIX: BANB) Peter Grogg, passed away on Monday, June 2, 2025, at the age of 83. Peter Grogg founded... ► Artikel lesen | |
UNITED THERAPEUTICS | 246,70 | +1,56 % | United Therapeutics completes enrollment for phase 3 PAH drug study | ||
CATALENT | 59,93 | 0,00 % | GenSight Biologics Announces Significant Milestone in New Manufacturing Partnership with Catalent | Upstream phase of LUMEVOQ manufacturing process successfully transferred
Milestone follows successful manufacture of drug product batch to be used for named early access program (AAC) and... ► Artikel lesen | |
INMED PHARMACEUTICALS | 2,880 | -2,70 % | InMed Pharmaceuticals Announces $5 Million Private Placement Priced At-the-Market Under Nasdaq Rules | Vancouver, British Columbia--(Newsfile Corp. - June 25, 2025) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical company focused on developing a pipeline of proprietary... ► Artikel lesen | |
OTSUKA HOLDINGS | 41,400 | 0,00 % | Harbour BioMed Enters Global Strategic Collaboration with Otsuka to Advance BCMAxCD3 Bispecific T-Cell Engagers | CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, June 22, 2025 /PRNewswire/ -- Harbour BioMed (HKEX: 02142), a global biopharmaceutical company committed... ► Artikel lesen | |
HUTCHMED | 2,500 | -2,34 % | HUTCHMED (00013): NOMINATION COMMITTEE - TERMS OF REFERENCE | ||
MEDICURE | 0,765 | 0,00 % | Medicure, Inc.: Medicure Announces Closing of Purchase Agreement for The Acquisition of West Olympia Pharmacy | WINNIPEG, MB / ACCESS Newswire / June 17, 2025 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals... ► Artikel lesen |